KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 97 filers reported holding KURA ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,255,000 | -19.6% | 89,612 | +7.6% | 0.04% | -4.3% |
Q3 2021 | $1,560,000 | -25.1% | 83,266 | -16.6% | 0.05% | -27.7% |
Q2 2021 | $2,082,000 | -40.7% | 99,862 | -19.6% | 0.06% | -35.0% |
Q1 2021 | $3,512,000 | +41.8% | 124,240 | +63.9% | 0.10% | +11.1% |
Q4 2020 | $2,476,000 | -20.8% | 75,800 | -25.7% | 0.09% | -44.1% |
Q3 2020 | $3,127,000 | +308.8% | 102,066 | +104.1% | 0.16% | -49.7% |
Q4 2017 | $765,000 | – | 50,000 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |